IN2015KN00370A - - Google Patents

Download PDF

Info

Publication number
IN2015KN00370A
IN2015KN00370A IN370KON2015A IN2015KN00370A IN 2015KN00370 A IN2015KN00370 A IN 2015KN00370A IN 370KON2015 A IN370KON2015 A IN 370KON2015A IN 2015KN00370 A IN2015KN00370 A IN 2015KN00370A
Authority
IN
India
Prior art keywords
skin
photoaging
signs
essential oil
aging
Prior art date
Application number
Inventor
Agnès Pegeon
Pascale Pelletier
Pierre Lartaud
Corinne Ferraris
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1257885A external-priority patent/FR2994528B1/en
Priority claimed from FR1257886A external-priority patent/FR2994529B1/en
Application filed by Oreal filed Critical Oreal
Publication of IN2015KN00370A publication Critical patent/IN2015KN00370A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Abstract

The present invention relates to the cosmetic use of the essential oil of Laserpitium siler L., as an active agent for preventing and/or treating the signs of aging or photoaging of the skin and as an antioxidant. It also targets a method for cosmetic treatment of the skin in order to combat the signs of skin aging or photoaging and/or to prevent and/or treat skin disorders induced by an oxidative stress and also a composition comprising an essential oil of Laserpitium siler L.
IN370KON2015 2012-08-20 2013-08-20 IN2015KN00370A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR1257885A FR2994528B1 (en) 2012-08-20 2012-08-20 COSMETIC USE OF THE ESSENTIAL OIL OF LASERPITIUM SILER L. AGAINST THE SKIN SIGNS OF AGING.
FR1257886A FR2994529B1 (en) 2012-08-20 2012-08-20 COSMETIC USE OF LASERPITIUM ESSENTIAL OIL SILER L. AS ANTIOXIDANT AGENT.
US201261714953P 2012-10-17 2012-10-17
US201261714991P 2012-10-17 2012-10-17
PCT/IB2013/056750 WO2014030117A2 (en) 2012-08-20 2013-08-20 Cosmetic use of the essential oil of laserpitium siler l. against the signs of aging of the skin and as an antioxidant

Publications (1)

Publication Number Publication Date
IN2015KN00370A true IN2015KN00370A (en) 2015-07-10

Family

ID=50150441

Family Applications (1)

Application Number Title Priority Date Filing Date
IN370KON2015 IN2015KN00370A (en) 2012-08-20 2013-08-20

Country Status (7)

Country Link
US (2) US10328018B2 (en)
EP (1) EP2885055B1 (en)
JP (1) JP6382197B2 (en)
CN (1) CN105050662B (en)
ES (1) ES2714948T3 (en)
IN (1) IN2015KN00370A (en)
WO (1) WO2014030117A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3015282B1 (en) 2013-12-20 2016-01-22 Oreal COSMETIC USE OF AN ESSENTIAL OIL OF LASERPITIUM SILER L. FOR KERATINIC MATERIALS.
FR3015281B1 (en) * 2013-12-20 2016-01-22 Oreal COSMETIC USE OF AN ESSENTIAL OIL OF LASERPITIUM SILER L. FOR LIGHTENING KERATINIC MATERIALS
JP6572337B2 (en) * 2018-02-28 2019-09-04 株式会社ファンケル Composition for promoting myokine production
KR102485259B1 (en) * 2018-03-27 2023-01-06 (주)아모레퍼시픽 Liquid lipid composite composition for improving hair condition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2796990B2 (en) 1989-05-10 1998-09-10 株式会社資生堂 Skin cosmetics
WO1999047110A1 (en) 1998-03-16 1999-09-23 Unilever Plc Cosmetic method of treating skin
FR2777186B1 (en) 1998-04-10 2001-03-09 Oreal USE OF AT LEAST ONE HYDROXYSTILBENE IN A FIRMING COMPOSITION
DE19915102A1 (en) * 1999-04-01 2000-10-05 Pohl Boskamp Gmbh Chem Pharma Treatment of cellular damage and disorders caused by reactive oxygen species e.g. atherosclerosis, ischemias or schizophrenia, by administration of limonene or oil containing it
US20040161436A1 (en) 2003-02-13 2004-08-19 Hull Barbara A. Skin treatment composition and method
FR2859908A1 (en) 2003-09-24 2005-03-25 Oreal Topically or orally administered composition for combating cutaneous aging symptoms, especially wrinkles, containing metalloproteinase inhibitor and myorelaxant or relaxant
KR100812596B1 (en) 2006-12-15 2008-03-13 바이오스펙트럼 주식회사 Compositions comprising compounds of natural origin for damaged skin
CZ300806B6 (en) 2007-07-18 2009-08-12 Ústav experimentální mediciny AV CR, v.v.i. Immunostimulating effects of trilobolide and process for preparing thereof
FR2930154B1 (en) 2008-04-21 2012-04-20 Oreal USE OF A BAY EXTRACT, AND ESPECIALLY OF WOLFBERRY, TO MAINTAIN AND / OR RESTORE THE TONICITY AND / OR FERTILIZATION OF THE SKIN
FR2956582B1 (en) * 2010-02-19 2012-08-24 Oreal POWDER COMPOSITION COMPRISING AT LEAST ONE LOAD, AT LEAST ONE ESSENTIAL OIL AND AT LEAST ONE HYDROXYL ESTER OF POLYOL AND (S) CARBOXYLIC ACID (S) IN C4 TO C16
FR2959666B1 (en) 2010-05-07 2012-07-20 Oreal FOAMING COSMETIC COMPOSITION BASED ON ELLAGIC ACID OR ONE OF ITS DERIVATIVES AND ESSENTIAL OIL.
FR2962328B1 (en) 2010-07-12 2013-03-08 Oreal METHOD FOR TREATING HUMAN BODILY ODORS USING A NON-RINSE COMPOSITION BASED ON A 2-ALCOXY-4-ALKYLCETONE PHENOL COMPOUND AND ESSENTIAL OIL
FR2968987B1 (en) 2010-12-17 2013-04-26 Oreal BUPLEVRE ESSENTIAL OIL

Also Published As

Publication number Publication date
CN105050662A (en) 2015-11-11
US20150231057A1 (en) 2015-08-20
US10328018B2 (en) 2019-06-25
WO2014030117A3 (en) 2014-10-23
JP2015530376A (en) 2015-10-15
JP6382197B2 (en) 2018-08-29
CN105050662B (en) 2018-04-13
WO2014030117A2 (en) 2014-02-27
EP2885055A2 (en) 2015-06-24
US20190328650A1 (en) 2019-10-31
EP2885055B1 (en) 2018-12-19
ES2714948T3 (en) 2019-05-30
WO2014030117A4 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
CL2019001878A1 (en) MicroRNA compounds and methods of modulation of mir-21 activity (divisional application 201402844).
PH12020500352A1 (en) Therapeutic uses of empagliflozin
IN2015DN02938A (en)
EA201291031A1 (en) METHOD OF TREATING OBESITY WITH THE USE OF ANTIOXIDANT INFLAMMATION MODULATORS
EA201591367A1 (en) CONNECTIONS RESORTS FOR DERMATOLOGICAL APPLICATIONS
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
MX2015001250A (en) Compositions and treatment for eye diseases and disorders.
UA114705C2 (en) Androgen composition for treating an opthalmic condition
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
BRPI1000320B8 (en) COMPOSITIONS AND METHODS TO TREAT SIGNS OF SKIN AGING
EA201500996A1 (en) THERAPEUTIC APPLICATIONS OF EMAGOGLIFLOSINE
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
MX2015003701A (en) Treatment compositions.
MX365366B (en) Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne.
TN2015000255A1 (en) Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
MX2016016407A (en) Thermosetting biophotonic compositions and uses thereof.
IN2014DE01913A (en)
IN2014KN02914A (en)
MX359181B (en) Collagen hydrolysate and use thereof.
IN2015KN00370A (en)
PH12016501159A1 (en) Compositions of omega 3 fatty acids to treat diseases which involve damage to the nervous system
MX2013015419A (en) Dha and epa in the reduction of oxidative stress.
BR112015020182A2 (en) cosmetic use of cheuin or a precursor or derivative thereof as an active ingredient, use of cheuin or a precursor or derivative thereof as an active ingredient, cosmetic composition and cosmetic treatment process to prevent and / or treat signs of skin aging and / or cutaneous attachments
WO2015050686A3 (en) Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis